Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 3Completed 3Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Sarcoma 1NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 51Gastro-enteropancreatic neuroendocrine tumor 10Carcinoma, Neuroendocrine 8Small Cell Lung Carcinoma 6Adenoma, Islet Cell 6Colorectal Neoplasms 4Cholangiocarcinoma 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Carcinoid Tumor 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Salivary Gland Neoplasms 2Pheochromocytoma 2Paraganglioma 2Pancreatic Neoplasms 2Neoplasms, Unknown Primary 2Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Medullary 2Brain Neoplasms 2Biliary Tract Neoplasms 2Vulvar Neoplasms 1Vipoma 1Urinary Bladder Neoplasms 1Thyroid cancer, medullary 1Thyroid Cancer, Papillary 1Thymus Neoplasms 1Testicular Neoplasms 1

Interventions

E-7386 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Digestive System Neoplasms × NET × Clear all
NCT03833700 2026-02-27

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Eisai Inc.

Phase 1 Active not recruiting
70 enrolled
EndocrineGastrointestinalNETSarcoma

Gastro-enteropancreatic neuroendocrine tumor, Digestive System Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Desmoid Tumors, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡